Sign in

Private company

Thorne Healthtech, Inc.

Thorne Healthtech, Inc. is an American pharmaceutical preparations company based in New York.2

Last updated Oct 21, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersNew York, United States2
  • Incorporated inDE3
  • Business address620 Omni Industrial Blvd., Summerville, Sc 294833
  • Filer category, Emerging growth company3
  • Legal formCorporation2
  • LEI549300VD2OYCM2I1IQ172
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O CORPORATION SERVICE COMPANY, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 48378722

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

50.2%Gross margin4
2.4%Operating margin4
6.9%Net margin4
24.1%Revenue growth, 20224
10.7%Return on equity4
0.09×Debt to equity4
-$11.9MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue50¢$113.8M
  • Research and development3¢$7.4M
  • Selling, general and admin33¢$75.6M
  • Other costs4¢$8.9M
  • Income tax3¢$7.3M
  • Profit7¢$15.7M

Out of $228.7M in revenue.4

Where each dollar of operating cash went, fiscal 2022

  • Capital spending100¢$17.1M

Out of $5.2M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.4

Financial statements

Revenue54$228.7M in 2022+65% since 2020
0$100.0M$200.0M$300.0M2020: $138.5M$138.5M20202021: $184.3M$184.3M2021+33%2022: $228.7M$228.7M2022+24%
Gross profit54$114.9M in 2022+77% since 2020
0$50.0M$100.0M$150.0M2020: $64.8M$64.8M20202021: $96.4M$96.4M2021+49%2022: $114.9M$114.9M2022+19%
Operating income54$5.5M in 2022+440% since 2020
0$2.5M$5.0M$7.5M$10.0M2020: $1.0M$1.0M20202021: $9.8M$9.8M2021+861%2022: $5.5M$5.5M2022−44%
Net income54$15.7M in 2022
-$5.0M0$5.0M$10.0M$15.0M$20.0M2020: -$3.4M-$3.4M20202021: $7.3M$7.3M20212022: $15.7M$15.7M2022+116%
Fiscal year2019202020212022
Revenue$138.5M5$184.3M4$228.7M4
Cost of revenue$73.7M5$87.9M4$113.8M4
Gross profit$64.8M5$96.4M4$114.9M4
Research and development$4.2M5$5.9M4$7.4M4
Selling, general and admin$48.4M5$56.4M4$75.6M4
Operating income$1.0M5$9.8M4$5.5M4
Income before tax$10.9M4$7.8M4
Income tax$176.8K5$411.9K4-$7.3M4
Net income-$3.4M5$7.3M4$15.7M4
Earnings per share-$0.345$0.144$0.304
Earnings per share (diluted)-$0.345$0.104$0.304
Shares (weighted, basic)27.5M shares452.8M shares4
Shares (weighted, diluted)32.3M shares452.8M shares4

Compare Thorne Healthtech, Inc. with another company

Corporate structure

Thorne Healthtech, Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Thorne Healthtech, Inc.

  • Thorne Healthtech, Inc. New York, New York, United States

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Thorne Healthtech, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$40.7M4 Dec 31, 2022$36.1M4 Dec 31, 2021+12.7%
Accumulated depreciation$13.4M4 Dec 31, 2022$11.3M4 Dec 31, 2021+18.8%
Property and equipment, net$49.2M4 Dec 31, 2022$27.0M4 Dec 31, 2021+81.9%
Finance-lease assets$3.1M4 Dec 31, 2022$883.1K4 Dec 31, 2021+256.0%
Operating-lease assets (leased space)$17.5M4 Dec 31, 2022$17.8M4 Dec 31, 2021−1.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$36.0M4 Dec 31, 2022$51.1M4 Dec 31, 2021−29.5%
Stakes in other companies (equity method)$942.5K4 Dec 31, 2022$963.7K4 Dec 31, 2021−2.2%
Long-term investments$1.4M4 Dec 31, 2022$400.0K4 Dec 31, 2021+250.0%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$20.0M4 Dec 31, 2022$14.4M4 Dec 31, 2021+38.8%
Intangible assets, net (excluding goodwill)$11.8M4 Dec 31, 2022$6.6M4 Dec 31, 2021+79.5%
Finite-lived intangibles, gross$26.1M4 Dec 31, 2022$27.7M4 Dec 31, 2021−5.8%
Accumulated amortization$14.3M4 Dec 31, 2022$21.1M4 Dec 31, 2021−32.4%
Finite-lived intangibles, net$11.8M4 Dec 31, 2022$6.6M4 Dec 31, 2021+79.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$58.6M4 Dec 31, 2022$41.0M4 Dec 31, 2021+43.0%
Raw materials$35.3M4 Dec 31, 2022$22.6M4 Dec 31, 2021+56.1%
Work in process$292.2K4 Dec 31, 2022$422.2K4 Dec 31, 2021−30.8%
Finished goods$23.5M4 Dec 31, 2022$18.4M4 Dec 31, 2021+27.6%

Leadership

Who has led Thorne Healthtech, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Paul F. Jacobson2021–2023

President

  1. William C. McCamy2021–2023

Chief financial officer

  1. Scott Wheeler2021–2022
  2. Bryan K. Conley2022
  3. Saloni S. Varma2023

Chief operating officer

  1. Thomas P. McKenna2021–2023
2025
Board members and other officers (9)

Timeline

  1. Oct 16, 20238-K Entered a material agreement; Ended a material agreement; Completed an acquisition or sale21
  2. Sep 27, 20238-K Other events22
  3. Sep 18, 20238-K Listing notice or transfer; Other events23
  4. Aug 31, 20238-K Entered a material agreement; Executive or director change24
  5. Aug 28, 20238-K Entered a material agreement; Other events25
  6. Aug 16, 20238-K Executive or director change26
  7. Aug 8, 20238-K Results of operations27
  8. Jun 14, 20238-K Shareholder vote28
  9. Jun 13, 20238-K Listing notice or transfer29
  10. Jun 1, 20238-K Entered a material agreement; Executive or director change30
  11. May 11, 20238-K Results of operations31
  12. Apr 3, 20238-K Results of operations32
  13. Sep 22, 2021New chief executive Paul F. Jacobson becomes CEO8

Calendar

When it reported results

  1. Aug 8, 2023Reported quarterly or annual results27
  2. May 11, 2023Reported quarterly or annual results31
  3. Apr 3, 2023Reported quarterly or annual results32
  4. Mar 30, 2023Reported quarterly or annual results33
  5. Nov 9, 2022Reported quarterly or annual results34
  6. Aug 9, 2022Reported quarterly or annual results35
  7. May 11, 2022Reported quarterly or annual results36
  8. Mar 16, 2022Reported quarterly or annual results37

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

106 filings to the SEC since October 2021: 2 annual reports, 6 quarterly reports, 31 major events, 42 insider forms, 7 large holders, 18 other. The latest 20:

  1. Nov 6, 2023SC 13G/A EDGAR
  2. Oct 26, 202315-12G EDGAR
  3. Oct 18, 20234 FORM 4 SUBMISSION EDGAR
  4. Oct 18, 20234 FORM 4 SUBMISSION EDGAR
  5. Oct 18, 20234 FORM 4 SUBMISSION EDGAR
  6. Oct 18, 20234 FORM 4 SUBMISSION EDGAR
  7. Oct 18, 20234 FORM 4 SUBMISSION EDGAR
  8. Oct 18, 20234 FORM 4 SUBMISSION EDGAR
  9. Oct 18, 20234/A FORM 4/A SUBMISSION EDGAR
  10. Oct 18, 20234/A FORM 4/A SUBMISSION EDGAR
  11. Oct 18, 20234/A FORM 4/A SUBMISSION EDGAR
  12. Oct 18, 20234/A FORM 4/A SUBMISSION EDGAR
  13. Oct 18, 20234/A FORM 4/A SUBMISSION EDGAR
  14. Oct 17, 20234 FORM 4 SUBMISSION EDGAR
  15. Oct 17, 2023SC 13G/A EDGAR
  16. Oct 17, 20234 OWNERSHIP DOCUMENT EDGAR
  17. Oct 16, 2023S-8 POS EDGAR
  18. Oct 16, 2023S-8 POS EDGAR
  19. Oct 16, 2023S-8 POS EDGAR
  20. Oct 16, 20238-K EDGAR

The 106 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

1 open-market trades by officers, directors and large owners since October 2021: 1 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 23, 2022Varma Saloni S.Chief Financial OfficerBuy9,223$6.01$55.4KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Thorne Healthtech, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARThorne Healthtech, Inc.1
  • CIK0001844280
  • Employer ID (EIN)27-28772531
  • Filer status<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • Business address620 Omni Industrial Blvd., Summerville, SC 294831
  • Phone843-501-02861
  • Shares outstanding53,920,020 as of Aug 9, 20237
  • Public float$65.3M as of Jun 30, 20224
  • On EDGAR sinceApr 19, 20211
  • Filings156 in all: 4 (43), 8-K (29), 3 (16), 10-Q (6), S-1/A (6), 4/A (5), CORRESP (5), SC 13G (4)1
    All 32 form types

    UPLOAD (4), DRS/A (3), S-8 (3), S-8 POS (3), SC 13G/A (3), 10-K (2), 8-K/A (2), DEF 14A (2), DEFA14A (2), DRSLTR (2), SC 14D9/A (2), SC TO-T/A (2), 15-12G (1), 25-NSE (1), 424B4 (1), 8-A12B (1), ARS (1), CERT (1), DRS (1), EFFECT (1), S-1 (1), SC 14D9 (1), SC TO-T (1), SC14D9C (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2023
    Quarterly report (10-Q) Aug 9, 2023
    Proxy statement (DEF 14A) Apr 28, 2023
    Latest 8-K (8-K) Oct 16, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
    SEC EDGAROther events
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41